Newman AH - Search Results

1

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.

Adhikari P, Xie B, Semeano A, Bonifazi A, Battiti FO, Newman AH, Yano H, Shi L. Adhikari P, et al. Among authors: newman ah. Biomolecules. 2021 Apr 13;11(4):570. doi: 10.3390/biom11040570. Biomolecules. 2021. PMID: 33924613 Free PMC article.

2

(+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.

Shah JH, Kline RH, Geter-Douglass B, Izenwasser S, Witkin JM, Newman AH. Shah JH, et al. Among authors: newman ah. J Med Chem. 1996 Aug 16;39(17):3423-8. doi: 10.1021/jm960143p. J Med Chem. 1996. PMID: 8765528

3

Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.

Robarge MJ, Husbands SM, Kieltyka A, Brodbeck R, Thurkauf A, Newman AH. Robarge MJ, et al. Among authors: newman ah. J Med Chem. 2001 Sep 13;44(19):3175-86. doi: 10.1021/jm010146o. J Med Chem. 2001. PMID: 11543687

4

N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists.

Newman AH, Cao J, Bennett CJ, Robarge MJ, Freeman RA, Luedtke RR. Newman AH, et al. Bioorg Med Chem Lett. 2003 Jul 7;13(13):2179-83. doi: 10.1016/s0960-894x(03)00389-5. Bioorg Med Chem Lett. 2003. PMID: 12798330

5

Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.

Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH. Grundt P, et al. Among authors: newman ah. J Med Chem. 2005 Feb 10;48(3):839-48. doi: 10.1021/jm049465g. J Med Chem. 2005. PMID: 15689168

6

Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.

Newman AH, Grundt P, Nader MA. Newman AH, et al. J Med Chem. 2005 Jun 2;48(11):3663-79. doi: 10.1021/jm040190e. J Med Chem. 2005. PMID: 15916415 Review. No abstract available.

7

Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.

Grundt P, Husband SL, Luedtke RR, Taylor M, Newman AH. Grundt P, et al. Among authors: newman ah. Bioorg Med Chem Lett. 2007 Feb 1;17(3):745-9. doi: 10.1016/j.bmcl.2006.10.076. Epub 2006 Oct 28. Bioorg Med Chem Lett. 2007. PMID: 17095222 Free PMC article.

8

Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.

Grundt P, Prevatt KM, Cao J, Taylor M, Floresca CZ, Choi JK, Jenkins BG, Luedtke RR, Newman AH. Grundt P, et al. Among authors: newman ah. J Med Chem. 2007 Aug 23;50(17):4135-46. doi: 10.1021/jm0704200. Epub 2007 Aug 2. J Med Chem. 2007. PMID: 17672446

9

The binding sites for cocaine and dopamine in the dopamine transporter overlap.

Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, Gether U, Loland CJ. Beuming T, et al. Among authors: newman ah. Nat Neurosci. 2008 Jul;11(7):780-9. doi: 10.1038/nn.2146. Epub 2008 Jun 22. Nat Neurosci. 2008. PMID: 18568020 Free PMC article.

10

Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol.

Paul NM, Taylor M, Kumar R, Deschamps JR, Luedtke RR, Newman AH. Paul NM, et al. Among authors: newman ah. J Med Chem. 2008 Oct 9;51(19):6095-109. doi: 10.1021/jm800532x. Epub 2008 Sep 6. J Med Chem. 2008. PMID: 18774793 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters